Pancreatic Cancer Research

ResearcherOsaka City UniversityNo recent work listed

Kosei Hirakawa

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5032903747. Sources: OpenAlex.

Their work

Papers
15 (first author 0, last author 9)
Trials
0
Grants
0
Labs led
1
Collaborators
28
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: 4 papers · 2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: 3 papers · 2018: 2 papers

Papers 15

  1. Pancreatic Cancer Cell Fraction Estimation in a DNA Sample. Co-author DOI 10.1159/000491637↗
  2. [A Case of Male Breast Cancer Suspected of Breast Metastasis from Pancreatic Cancer]. Co-author PMID 30692377↗
  3. Analysis of the origin of anaplastic pancreatic cancer and the mechanism of its dedifferentiation. Co-author DOI 10.1002/jhbp.429↗
  4. Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study. Co-author DOI 10.1111/cas.13113↗
  5. Preoperative predictors for early recurrence of resectable pancreatic cancer. Co-author DOI 10.1186/s12957-016-1078-z↗
  6. Establishment and characterization of new cell lines of anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2. Last author DOI 10.1186/s12885-016-2297-y↗
  7. Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia. Last author DOI 10.1371/journal.pone.0159912↗
  8. Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresecta… Last author DOI 10.1016/j.surg.2015.02.016↗
  9. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma. Last author DOI 10.1186/1477-7819-12-360↗
  10. IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer. Last author DOI 10.1186/1471-2407-13-392↗
  11. MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways. Co-author DOI 10.3892/ijo.2013.1760↗
  12. In vitro effects of lapatinib with gemcitabine for pancreatic cancer cells. Last author DOI 10.5754/hge13195↗
  13. [A case of locally advanced pancreatic cancer with hepatic artery invasion treated with neoadjuvant chemoradiotherapy]. Last author PMID 24393948↗
  14. Identification of HLA-A*0201- and A*2402-restricted epitopes of mucin 5AC expressed in advanced pancreatic cancer. Last author DOI 10.1097/mpa.0b013e31821ad8d1↗
  15. HER3 overexpression as an independent indicator of poor prognosis for patients with curatively resected pancreatic cancer. Last author DOI 10.1159/000333825↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kenjiro Kimura · 13 shared papers, 2011–2018 · strength 0.67
  2. Ryosuke Amano · 13 shared papers, 2011–2018 · strength 0.65
  3. Masaichi Ohira · 8 shared papers, 2011–2018 · strength 0.39
  4. Sadaaki Yamazoe · 7 shared papers, 2011–2018 · strength 0.39
  5. Kohei Nishio · 4 shared papers, 2014–2017 · strength 0.24
  6. Akihiro Murata · 5 shared papers, 2013–2016 · strength 0.20
  7. Kotaro Miura · 3 shared papers, 2014–2017 · strength 0.16
  8. Toshiki Hirakawa · 4 shared papers, 2011–2016 · strength 0.16
  9. Masakazu Yashiro · 3 shared papers, 2013–2016 · strength 0.15
  10. Hiroki Ishihara · 1 shared paper, 2018 · strength 0.07
  11. Norifumi Kawada · 1 shared paper, 2018 · strength 0.07
  12. Koji Takada · 1 shared paper, 2018 · strength 0.07
  13. Toshikazu Ushijima · 1 shared paper, 2018 · strength 0.07
  14. Haruo Iguchi · 1 shared paper, 2017 · strength 0.05
  15. Masaaki Oka · 1 shared paper, 2017 · strength 0.05
  16. Tomio Ueno · 1 shared paper, 2017 · strength 0.05
  17. Takashi Hatori · 1 shared paper, 2017 · strength 0.05
  18. Hiroaki Nagano · 1 shared paper, 2017 · strength 0.05
  19. Yoshitaro Shindo · 1 shared paper, 2017 · strength 0.05
  20. Nobuaki Suzuki · 1 shared paper, 2017 · strength 0.05
  21. Tetsuya Ikemoto · 1 shared paper, 2017 · strength 0.05
  22. Yuzo Umeda · 1 shared paper, 2017 · strength 0.05
  23. Mitsuo Shimada · 1 shared paper, 2017 · strength 0.05
  24. Hiroto Matsui · 1 shared paper, 2017 · strength 0.05
  25. Yusuke Nakamura · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.